Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 05/14/24
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024GlobeNewsWire • 05/07/24
Will Adherex Technologies Inc. (FENC) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 05/02/24
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/21/24
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 03/21/24
Adherex Technologies Inc. (FENC) is on the Move, Here's Why the Trend Could be SustainableZacks Investment Research • 03/19/24
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024GlobeNewsWire • 03/19/24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandGlobeNewsWire • 03/18/24
Wall Street Analysts See a 64.61% Upside in Adherex Technologies Inc. (FENC): Can the Stock Really Move This High?Zacks Investment Research • 03/13/24
Fennec Pharmaceuticals: Great Sales Progress - Not Yet Reflected In Stock PriceSeeking Alpha • 03/07/24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 ResultsGlobeNewsWire • 02/29/24
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving CisplatinGlobeNewsWire • 02/01/24
Recent Price Trend in Adherex Technologies Inc. (FENC) is Your Friend, Here's WhyZacks Investment Research • 12/21/23
Wall Street Analysts Think Adherex Technologies Inc. (FENC) Could Surge 81%: Read This Before Placing a BetZacks Investment Research • 11/27/23
Wall Street Analysts Believe Adherex Technologies Inc. (FENC) Could Rally 109.97%: Here's is How to TradeZacks Investment Research • 11/09/23